Sei Investments CO Repligen Corp Transaction History

Sei Investments CO

  • $66.7 Billion
  • Q1 2024

A detailed history of Sei Investments CO transactions in Repligen Corp stock. As of the latest transaction made, Sei Investments CO holds 218,714 shares of RGEN stock, worth $27.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
218,714
Previous 258,941 15.54%
Holding current value
$27.6 Million
Previous $46.6 Million 13.6%
% of portfolio
0.06%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$170.78 - $208.42 $6.87 Million - $8.38 Million
-40,227 Reduced 15.54%
218,714 $40.2 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $806,496 - $1.31 Million
7,064 Added 2.8%
258,941 $46.6 Million
Q3 2023

Nov 14, 2023
BUY
$138.78 - $176.51 $8.99 Million - $11.4 Million
64,774 Added 34.62%
251,877 $40.1 Million
Q2 2023

Aug 11, 2023
BUY
$138.42 - $180.31 $6.65 Million - $8.67 Million
48,061 Added 34.57%
187,103 $26.5 Million
Q1 2023

May 12, 2023
BUY
$154.26 - $198.1 $54,916 - $70,523
356 Added 0.26%
139,042 $23.4 Million
Q4 2022

Feb 10, 2023
SELL
$162.42 - $220.56 $1.46 Million - $1.98 Million
-8,984 Reduced 6.08%
138,686 $23.5 Million
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $5.76 Million - $9.2 Million
35,904 Added 32.12%
147,670 $27.6 Million
Q2 2022

Aug 15, 2022
BUY
$140.68 - $188.02 $7.29 Million - $9.75 Million
51,849 Added 86.53%
111,766 $18.1 Million
Q1 2022

May 13, 2022
BUY
$161.19 - $257.96 $1.51 Million - $2.41 Million
9,352 Added 18.5%
59,917 $11.3 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $2.22 Million - $2.73 Million
8,963 Added 21.54%
50,565 $13.4 Million
Q3 2021

Nov 12, 2021
BUY
$194.77 - $324.21 $2.67 Million - $4.44 Million
13,684 Added 49.01%
41,602 $11.9 Million
Q2 2021

Aug 06, 2021
BUY
$165.87 - $220.95 $963,207 - $1.28 Million
5,807 Added 26.26%
27,918 $5.57 Million
Q1 2021

May 12, 2021
BUY
$180.37 - $226.26 $1.77 Million - $2.22 Million
9,806 Added 79.69%
22,111 $4.28 Million
Q4 2020

Feb 08, 2021
SELL
$148.08 - $206.57 $572,625 - $798,806
-3,867 Reduced 23.91%
12,305 $2.36 Million
Q3 2020

Dec 04, 2020
SELL
$122.51 - $158.27 $52,801 - $68,214
-431 Reduced 2.6%
16,172 $2.38 Million
Q3 2020

Nov 06, 2020
BUY
$122.51 - $158.27 $845,686 - $1.09 Million
6,903 Added 71.16%
16,603 $2.45 Million
Q2 2020

Aug 17, 2020
SELL
$94.33 - $140.48 $790,202 - $1.18 Million
-8,377 Reduced 46.34%
9,700 $1.2 Million
Q2 2020

Aug 11, 2020
SELL
$94.33 - $140.48 $474,102 - $706,052
-5,026 Reduced 21.75%
18,077 $1.85 Million
Q1 2020

May 14, 2020
BUY
$84.96 - $109.14 $299,993 - $385,373
3,531 Added 18.04%
23,103 $2.23 Million
Q4 2019

Feb 06, 2020
SELL
$73.84 - $93.08 $28,723 - $36,208
-389 Reduced 1.95%
19,572 $1.81 Million
Q3 2019

Nov 12, 2019
BUY
$76.65 - $95.51 $8,738 - $10,888
114 Added 0.57%
19,961 $1.54 Million
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $896,847 - $1.42 Million
16,547 Added 501.42%
19,847 $1.7 Million
Q1 2019

May 15, 2019
SELL
$49.45 - $62.8 $2.23 Million - $2.83 Million
-45,085 Reduced 93.18%
3,300 $198,000
Q4 2018

Feb 13, 2019
BUY
$48.26 - $68.88 $867,859 - $1.24 Million
17,983 Added 59.15%
48,385 $2.63 Million
Q3 2018

Nov 08, 2018
SELL
$46.8 - $58.97 $2.36 Million - $2.97 Million
-50,335 Reduced 62.34%
30,402 $1.69 Million
Q2 2018

Aug 03, 2018
SELL
$35.26 - $47.04 $109,306 - $145,824
-3,100 Reduced 3.7%
80,737 $3.8 Million
Q1 2018

May 11, 2018
SELL
$30.92 - $37.27 $2.59 Million - $3.12 Million
-83,787 Reduced 49.99%
83,837 $3.03 Million
Q4 2017

Feb 08, 2018
BUY
$32.53 - $38.92 $296,803 - $355,106
9,124 Added 5.76%
167,624 $6.08 Million
Q3 2017

Nov 06, 2017
BUY
$36.98 - $46.06 $5.86 Million - $7.3 Million
158,500
158,500 $6.07 Million

Others Institutions Holding RGEN

# of Institutions
522
Shares Held
53.2M
Call Options Held
1.05M
Put Options Held
228K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email